ACKNOWLEDGMENTS
AbbVie and the authors thank all of the study investigators for their contributions and the patients who participated in this study. All authors had access to the data and participated in the development, review, critique, and approval of the manuscript throughout the editorial process, and approved the final manuscript draft submitted for publication. All authors agree to be accountable for all aspects of the work, ensuring the accuracy and integrity of the publication. All named authors meet the International Committee of Medical Journal Editors criteria for authorship for this article, take responsibility for the integrity of the work, and have given their approval for this version to be published. A.M. contributed to the study concept and design. K.M., Y.O., and A.M. contributed to data acquisition. I.Y. contributed to statistical analysis. I.Y., N.S., I.M., and A.M. contributed to data interpretation. AbbVie funded the research for this study and provided writing support for this manuscript. Medical writing support, funded by AbbVie, was provided by Melissa Julyanti, PharmD, of JB Ashtin. AbbVie is committed to responsible data sharing regarding the clinical trials we sponsor. This includes access to anonymized individual and trial‐level data (analysis data sets), as well as other information (e.g., protocols and clinical study reports), as long as the trials are not part of an ongoing or planned regulatory submission. This includes requests for clinical trial data for unlicensed products and indications. This clinical trial data can be requested by any qualified researchers who engage in rigorous, independent scientific research, and will be provided following review and approval of a research proposal and statistical analysis plan and execution of a data sharing agreement. Data requests can be submitted at any time and the data will be accessible for 12 months, with possible extensions considered. For more information on the process, or to submit a request, visit the following link: 